tiprankstipranks
Advertisement
Advertisement
AEON Biopharma Advances Biosimilar Program and Debt Reduction
PremiumCompany AnnouncementsAEON Biopharma Advances Biosimilar Program and Debt Reduction
2M ago
Aeon Biopharma reports BPD Type 2a meeting with FDA
Premium
The Fly
Aeon Biopharma reports BPD Type 2a meeting with FDA
2M ago
AEON Biopharma Releases Updated Investor Presentation Under Reg FD
Premium
Company Announcements
AEON Biopharma Releases Updated Investor Presentation Under Reg FD
3M ago
Aeon Biopharma reports Q3 EPS (39c) vs ($11.24) last year
PremiumThe FlyAeon Biopharma reports Q3 EPS (39c) vs ($11.24) last year
5M ago
AEON Biopharma Announces New Securities Purchase Agreement
Premium
Company Announcements
AEON Biopharma Announces New Securities Purchase Agreement
5M ago
Aeon Biopharma announces FDA BPD Type 2a meeting for ABP-450
Premium
The Fly
Aeon Biopharma announces FDA BPD Type 2a meeting for ABP-450
6M ago
AEON Biopharma Releases New Corporate Presentation
PremiumCompany AnnouncementsAEON Biopharma Releases New Corporate Presentation
11M ago
AEON Biopharma Appoints New CEO Robert Bancroft
Premium
Company Announcements
AEON Biopharma Appoints New CEO Robert Bancroft
11M ago
Aeon Biopharma appoints Rob Bancroft as CEO
Premium
The Fly
Aeon Biopharma appoints Rob Bancroft as CEO
11M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100